Tafluprost

What is Tafluprost

Tafluprost is a prostaglandin analog with a high affinity for the fluoroprostaglandin (FP) receptor.

It is indicated for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

In clinical studies, administration of tafluprost 0.0015% once daily to patients with open-angle glaucoma or ocular hypertension and a baseline IOP of 23—26 mmHg resulted in an IOP decrease of approximately 6—8 mmHg after 3 months and 5—8 mmHg after 6 months.

Brand Name

ZIOPTAN

Indications

  • glaucoma
  • increased intraocular pressure
  • ocular hypertension

For the reduction of increased intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Side Effects

  1. blurred vision
  2. cataracts
  3. conjunctival hyperemia
  4. conjunctivitis
  5. cough
  6. dyspnea
  7. headache
  8. infection
  9. iridal discoloration
  10. iritis
  11. macular edema
  12. ocular irritation
  13. ocular pain
  14. ocular pruritus
  15. skin hyperpigmentation
  16. uveitis
  17. xerophthalmia

Monitoring Parameters

  • intraocular pressure
  • ophthalmologic exam

Contraindications

  • aphakia
  • breast-feeding
  • children
  • infants
  • inflammation
  • iritis
  • neonates
  • pregnancy
  • uveitis

Interactions

There are no drug interactions associated with Tafluprost products.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top